SHH and hepatocellular carcinoma: In vivo experiments demonstrated that combining cyclopamine with radiotherapy, as opposed to radiotherapy alone, led to a significant decrease in orthotopic tumor size by about 67% (p < 0.05), indicating that the co-application of an SHH inhibitor with radiotherapy can boost the radiosensitivity of HCC cells [71].